NCT02454634: Phase I Trial of IDH1 Peptide Vaccine in IDH1R132H-mutated Grade III-IV Gliomas
- State
- Completed
- Phase
- Phase 1
- People
- 39 taking part
- Started
- Jun 2015
- Primary completion
- 19 Sep 2017
- Arms
- IDH1 peptide vaccine
- Results
- None posted
- 27 May 2015: Trial registered
- 19 Sep 2017: Trial completed